Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Miguel A. Hernandez-Esquivel"'
Autor:
Marco A. Velasco-Velázquez, Richard G. Pestell, Lenin Pavón, Alonso Reyes-Matute, Sonia Mayra Pérez-Tapia, Armando Pérez-Torres, Brenda Loaiza, Laura Romero-Romero, Miguel A. Hernandez-Esquivel, Gabriela Mellado-Sánchez, Emilio Medina-Rivero
Publikováno v:
Biomedicine & Pharmacotherapy. 101:938-944
Prostate cancer (PCa) is the second most frequently diagnosed cancer in men worldwide. Dialyzed Leukocyte Extracts (DLEs) are heterogeneous mixtures of low-molecular-weight peptides that improve clinical responses in various diseases. Here, we analyz
Autor:
Inés Velázquez-Quesada, Aldo Segura-Cabrera, Sandra L. Guerrero-Rodríguez, Charmina Aguirre-Alvarado, Carlos A. García-Pérez, Sonia Mayra Pérez-Tapia, Andrea Rodríguez-Moreno, Angel J Ruiz-Moreno, Miguel A. Hernandez-Esquivel, Marco A. Velasco-Velázquez
Publikováno v:
Oncotarget
CD44 is a receptor for hyaluronan (HA) that promotes epithelial-to-mesenchymal transition (EMT), induces cancer stem cell (CSC) expansion, and favors metastasis. Thus, CD44 is a target for the development of antineoplastic agents. In order to repurpo
Autor:
Marco A. Velasco-Velázquez, Sonia Mayra Pérez-Tapia, Richard G. Pestell, Miguel A. Hernandez-Esquivel
Publikováno v:
Cancer Research. 75:5201-5201
Prostate cancer remains the most common non-dermatological cancer in the United States and the second leading cause of cancer death amongst men. The majority of men with progressive prostate cancer develop metastases, being the skeleton the most prev